Product Information
ERYTHROMYCIN 0.5% EYE OINTMENT is a generic product labeled by Bausch & Lomb Incorporated, priced at $2.8266 per GM under NDC 24208091055. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jul 29, 1994. Its Orange Book therapeutic-equivalence code is AT.
Strength
5 mg/g
Manufacturer
Bausch & Lomb IncorporatedNDC
24208091055
Classification
Generic
Dosage Form
OINTMENT
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
ERYTHROMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA064067FDA Approved
7/29/1994
TE Code
AT
On Market Since
7/29/1994
Pharmacological Classes
Price Statistics
The NADAC for ERYTHROMYCIN 0.5% EYE OINTMENT has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 12.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.8266 per GM |
|---|---|
| All-time high | $3.6977 (Jul 15, 2020) |
| All-time low | $1.7586 (Sep 19, 2018) |
| 52-week high | $3.0117 |
| 52-week low | $2.7973 |
| Median price | $2.7671 |
| Average price | $2.7697 |
| Largest weekly change | +41.2% (May 22, 2019) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch & Lomb Incorporated manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Erythromycin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Macrolide Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN 0.5% EYE OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN 0.5% EYE OINTMENT, manufactured by Bausch & Lomb Incorporated, is $2.8266 per GM (NDC 24208091055), effective Sep 30, 2026.
How has the price of ERYTHROMYCIN 0.5% EYE OINTMENT changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN 0.5% EYE OINTMENT has declined 12.3%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN 0.5% EYE OINTMENT?
Since Nov 28, 2013, the NADAC for ERYTHROMYCIN 0.5% EYE OINTMENT has ranged from a low of $1.7586 (Sep 19, 2018) to a high of $3.6977 (Jul 15, 2020), with a median of $2.7671 per GM.
Are there cheaper alternatives to ERYTHROMYCIN 0.5% EYE OINTMENT?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ERYTHROMYCIN 0.5% EYE OINTMENT in a comparable dosage form, but none are currently priced below it.
Who manufactures ERYTHROMYCIN 0.5% EYE OINTMENT?
ERYTHROMYCIN 0.5% EYE OINTMENT (NDC 24208091055) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.